Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.
On Saturday, November 16, the Columbia University Department of Surgery hosted Lung Cancer Awareness Day at the medical center campus, in Washington Heights.
In August 2013, a large study published in the Journal of the National Cancer Institute found that following a high quality diet may help to reduce one’s risk for developing pancreatic cancer.
Utilizing the latest techniques in molecular biology and genetics, the married team of Cory Abate-Shen and Michael Shen are tackling metastatic prostate cancer.
Radiation exposure from breast cancer treatment is associated with a small risk of developing heart disease later in life, but the risk is now lower than it was 20 years ago.
Isobel Hoevers has co-founded a line of high-end medical ID jewelry that is both functional and fashionable, with a portion of the profits funding research at the Medical Center.
New findings suggest that narrow-spectrum UV light could dramatically reduce surgical infections – which remain a serious and stubborn problem, killing up to 8,200 patients a year in the U.S. – without damaging human tissue